About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Sunflower Therapeutics Engages PharmNXT Biotech LLP as Distributor for the Daisy Petal™ Perfusion Bioreactor System

Daisy Petal™ is now commercially launched and available for sale in India, Singapore, Thailand, Indonesia, Malaysia, and South Korea

Sunflower Therapeutics (Sunflower), a public benefit corporation transforming global access to protein manufacturing capacity for diverse applications, announced today its first distribution agreement with PharmNXT Biotech, an Indian bioprocessing company. Through this agreement, Sunflower will commercially launch its Daisy Petal™ Perfusion Bioreactor System in Asia, a significant step in the company’s ongoing product commercialization.

"The commercial launch of the Daisy Petal™ is a remarkable milestone for Sunflower Therapeutics," said Dr. Kerry R. Love, Founder and CEO of Sunflower Therapeutics. "We’re excited to partner with PharmNXT Biotech to introduce our products and services to a global market and establish ourselves as a global supplier of cutting-edge protein manufacturing solutions.”

Sunflower’s innovative Daisy Petal™ perfusion fermentation system uses a single-use assembly designed specifically for intuitive installation and a simple user experience. The system’s hardware and controls are engineered and optimized for in-vessel perfusion utilizing a custom disposable stirred tank reactor outfitted with a unique in-vessel perfusion device that enables greater volumetric productivity from the bench through scale-up manufacturing. With this approach, the system boasts space-time yield benefits five-to-ten times greater compared to traditional fed-batch methods for the production of diverse proteins.

“We are happy and proud to announce a strategic alliance with Sunflower Therapeutics,” said Ankush Kapoor, Co-founder and CEO of PharmNXT Biotech, and Sachin Joshi, Co-founder and Managing Director of PharmNXT Biotech. “Sunflower, with its innovative technologies, and PharmNXT, with our technical expertise and experience in Asia, are taking an important step forward in our collaboration by leveraging our strengths in efficiency and quality to make biopharmaceuticals affordable and accessible. We extend our sincere thanks to our partners Sunflower Therapeutics for sharing our mission and vision and for collaborating with us.”

In addition to the hardware, Sunflower’s bioprocessing software suite, which is compliant with Good Manufacturing Practices (GMP), includes HelianthOS™, Nursery™, and Harvest™. These tools enable walkaway automation of fermentation processes, easy to develop recipes that require no coding and secure storage of process data. Together, these three elements provide a cohesive ecosystem that enables efficient and intuitive operations throughout an entire campaign.

To learn more about Sunflower’s accessible approach to bioprocessing, please visit sunflowertx.com.

About Sunflower Therapeutics

Sunflower Therapeutics is a unique biotech with a mission to transform bioeconomies worldwide by creating accessible solutions for protein product development and commercial manufacturing. Using our core technologies – an efficient host, data-driven methods for process development, and continuous biomanufacturing equipment – our team aims to democratize bioprocessing.

About PharmNXT

PharmNXT Biotech is one of the fastest-growing multinational companies in the bioprocessing industry, headquartered in Mumbai, India. Established in 2017, the company is committed to delivering innovative, end-to-end bioprocess solutions and niche technologies to reduce the manufacturing costs of critical lifesaving drugs. In 2022 PharmNXT set up a state-of-the-art manufacturing facility – PharmNXT Ekuse, in Pune.

PharmNXT has expanded its global footprint, supplying products to 12 countries and establishing branches in Singapore and South Korea to support its international operations. With its in-house manufacturing capabilities and a team of experts, PharmNXT provides innovative and scalable bioprocess solutions that adhere to global quality standards. As a trusted partner in bioprocessing, PharmNXT is transforming the industry by making lifesaving drugs more accessible worldwide.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.